Immune vulnerability of ovarian cancer stem-like cells due to low CD47 expression is protected by surrounding bulk tumor cells

Recurrence of advanced epithelial ovarian cancer is common despite optimal surgical debulking and initial favorable responses to chemotherapy. Evidences suggest that cancer stem cells (CSCs) have inherent resistance to conventional therapies such as chemotherapy and play a decisive role in cancer re...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chih-Long, Wu, Chao-Chih, Hsu, Yun-Ting, Hsu, Yi-Chiung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458642/
https://www.ncbi.nlm.nih.gov/pubmed/32923164
http://dx.doi.org/10.1080/2162402X.2020.1803530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458642/
https://www.ncbi.nlm.nih.gov/pubmed/32923164
http://dx.doi.org/10.1080/2162402X.2020.1803530

Ejemplares similares